Help
RSS
API
Feed
Maltego
Contact
Domain > www.ix-therapeutics.com
×
Welcome!
Right click nodes and scroll the mouse to navigate the graph.
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-12-26
3.33.137.254
(
ClassC
)
2025-01-09
15.197.136.154
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: awselb/2.0Date: Sun, 24 Nov 2024 13:58:13 GMTContent-Type: text/htmlContent-Length: 134Connection: keep-aliveLocation: https://www.ix-therapeutics.com:443/ html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sun, 24 Nov 2024 13:58:14 GMTContent-Type: text/html; charsetutf-8Content-Length: 57694Connection: keep-aliveServer: ApacheVary: X-Forwarded-Port,Accept-EncodingContent-Language: !DOCTYPE html>html dirltr langen-us>head>meta charsetutf-8>!-- build by rosenbauersolbach.de This website is powered by TYPO3 - inspiring people to share! TYPO3 is a free open source Content Management Framework initially created by Kasper Skaarhoj and licensed under GNU/GPL. TYPO3 is copyright 1998-2024 of Kasper Skaarhoj. Extensions are copyright of their respective owners. Information and contribution at https://typo3.org/-->title>Ix Therapeutics/title>meta http-equivx-ua-compatible contentIEedge />meta namegenerator contentTYPO3 CMS />meta nameviewport contentwidthdevice-width, initial-scale1 />meta namerobots contentindex,follow />meta namedescription contentIx Therapeutics is a drug development company, established in 2021. Founded by Indivumed and funded by Xlife Sciences, the joint venture develops functional antibodies to treat cancer, based on novel and proprietary targets. />meta nametwitter:card contentsummary />meta nameapple-mobile-web-app-capable contentno />link relstylesheet href/typo3conf/ext/ix_therapeutics/Resources/Public/Css/main.min.css?1644413356 mediaall>script src/typo3conf/ext/ix_therapeutics/Resources/Public/JavaScript/Dist/gsap.min.js?1622744823>/script>script src/typo3conf/ext/ix_therapeutics/Resources/Public/JavaScript/Dist/ScrollTrigger.min.js?1622744824>/script>link relpreload asstyle hrefhttps://www.ix-therapeutics.com/fileadmin/sg_cookie_optin/siteroot-391/cookieOptin.css?1680526316 mediaall crossoriginanonymous>link relstylesheet hrefhttps://www.ix-therapeutics.com/fileadmin/sg_cookie_optin/siteroot-391/cookieOptin.css?1680526316 mediaall crossoriginanonymous>script idcookieOptinData typeapplication/json>{cookieGroups:{groupName:essential,label:Essenziell,description:Technically necessary cookies are required for basic website functions. This ensures that the website functions properly.,required:true,cookieData:{Name:cookie_optin,Provider:Indivumed,Purpose:This cookie is used to save your cookie settings for this website.,Lifetime:1 Year,index:0,crdate:1632903772,tstamp:168052
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]